Cargando…

A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy

Although literature suggests that resistance to TNF inhibitor (TNFi) therapy in patients with ulcerative colitis (UC) is partially linked to immune cell populations in the inflamed region, there is still substantial uncertainty underlying the relevant spatial context. Here, we used the highly multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Aaron T., Holman, Derek R., Sood, Anav, Tandon, Utkarsh, Bhate, Salil S., Bodapati, Sunil, Barlow, Graham L., Chang, Jeff, Black, Sarah, Crenshaw, Erica C., Koron, Alexander N., Streett, Sarah E., Gambhir, Sanjiv S., Sandborn, William J., Boland, Brigid S., Hastie, Trevor, Tibshirani, Robert, Chang, John T., Nolan, Garry P., Schürch, Christian M., Rogalla, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858501/
https://www.ncbi.nlm.nih.gov/pubmed/36662860
http://dx.doi.org/10.1126/sciadv.add1166
_version_ 1784874116819451904
author Mayer, Aaron T.
Holman, Derek R.
Sood, Anav
Tandon, Utkarsh
Bhate, Salil S.
Bodapati, Sunil
Barlow, Graham L.
Chang, Jeff
Black, Sarah
Crenshaw, Erica C.
Koron, Alexander N.
Streett, Sarah E.
Gambhir, Sanjiv S.
Sandborn, William J.
Boland, Brigid S.
Hastie, Trevor
Tibshirani, Robert
Chang, John T.
Nolan, Garry P.
Schürch, Christian M.
Rogalla, Stephan
author_facet Mayer, Aaron T.
Holman, Derek R.
Sood, Anav
Tandon, Utkarsh
Bhate, Salil S.
Bodapati, Sunil
Barlow, Graham L.
Chang, Jeff
Black, Sarah
Crenshaw, Erica C.
Koron, Alexander N.
Streett, Sarah E.
Gambhir, Sanjiv S.
Sandborn, William J.
Boland, Brigid S.
Hastie, Trevor
Tibshirani, Robert
Chang, John T.
Nolan, Garry P.
Schürch, Christian M.
Rogalla, Stephan
author_sort Mayer, Aaron T.
collection PubMed
description Although literature suggests that resistance to TNF inhibitor (TNFi) therapy in patients with ulcerative colitis (UC) is partially linked to immune cell populations in the inflamed region, there is still substantial uncertainty underlying the relevant spatial context. Here, we used the highly multiplexed immunofluorescence imaging technology CODEX to create a publicly browsable tissue atlas of inflammation in 42 tissue regions from 29 patients with UC and 5 healthy individuals. We analyzed 52 biomarkers on 1,710,973 spatially resolved single cells to determine cell types, cell-cell contacts, and cellular neighborhoods. We observed that cellular functional states are associated with cellular neighborhoods. We further observed that a subset of inflammatory cell types and cellular neighborhoods are present in patients with UC with TNFi treatment, potentially indicating resistant niches. Last, we explored applying convolutional neural networks (CNNs) to our dataset with respect to patient clinical variables. We note concerns and offer guidelines for reporting CNN-based predictions in similar datasets.
format Online
Article
Text
id pubmed-9858501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-98585012023-01-30 A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy Mayer, Aaron T. Holman, Derek R. Sood, Anav Tandon, Utkarsh Bhate, Salil S. Bodapati, Sunil Barlow, Graham L. Chang, Jeff Black, Sarah Crenshaw, Erica C. Koron, Alexander N. Streett, Sarah E. Gambhir, Sanjiv S. Sandborn, William J. Boland, Brigid S. Hastie, Trevor Tibshirani, Robert Chang, John T. Nolan, Garry P. Schürch, Christian M. Rogalla, Stephan Sci Adv Biomedicine and Life Sciences Although literature suggests that resistance to TNF inhibitor (TNFi) therapy in patients with ulcerative colitis (UC) is partially linked to immune cell populations in the inflamed region, there is still substantial uncertainty underlying the relevant spatial context. Here, we used the highly multiplexed immunofluorescence imaging technology CODEX to create a publicly browsable tissue atlas of inflammation in 42 tissue regions from 29 patients with UC and 5 healthy individuals. We analyzed 52 biomarkers on 1,710,973 spatially resolved single cells to determine cell types, cell-cell contacts, and cellular neighborhoods. We observed that cellular functional states are associated with cellular neighborhoods. We further observed that a subset of inflammatory cell types and cellular neighborhoods are present in patients with UC with TNFi treatment, potentially indicating resistant niches. Last, we explored applying convolutional neural networks (CNNs) to our dataset with respect to patient clinical variables. We note concerns and offer guidelines for reporting CNN-based predictions in similar datasets. American Association for the Advancement of Science 2023-01-20 /pmc/articles/PMC9858501/ /pubmed/36662860 http://dx.doi.org/10.1126/sciadv.add1166 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Mayer, Aaron T.
Holman, Derek R.
Sood, Anav
Tandon, Utkarsh
Bhate, Salil S.
Bodapati, Sunil
Barlow, Graham L.
Chang, Jeff
Black, Sarah
Crenshaw, Erica C.
Koron, Alexander N.
Streett, Sarah E.
Gambhir, Sanjiv S.
Sandborn, William J.
Boland, Brigid S.
Hastie, Trevor
Tibshirani, Robert
Chang, John T.
Nolan, Garry P.
Schürch, Christian M.
Rogalla, Stephan
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title_full A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title_fullStr A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title_full_unstemmed A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title_short A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
title_sort tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to tnf inhibitor therapy
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858501/
https://www.ncbi.nlm.nih.gov/pubmed/36662860
http://dx.doi.org/10.1126/sciadv.add1166
work_keys_str_mv AT mayeraaront atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT holmanderekr atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT soodanav atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT tandonutkarsh atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bhatesalils atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bodapatisunil atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT barlowgrahaml atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT changjeff atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT blacksarah atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT crenshawericac atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT koronalexandern atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT streettsarahe atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT gambhirsanjivs atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT sandbornwilliamj atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bolandbrigids atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT hastietrevor atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT tibshiranirobert atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT changjohnt atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT nolangarryp atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT schurchchristianm atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT rogallastephan atissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT mayeraaront tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT holmanderekr tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT soodanav tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT tandonutkarsh tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bhatesalils tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bodapatisunil tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT barlowgrahaml tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT changjeff tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT blacksarah tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT crenshawericac tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT koronalexandern tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT streettsarahe tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT gambhirsanjivs tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT sandbornwilliamj tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT bolandbrigids tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT hastietrevor tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT tibshiranirobert tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT changjohnt tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT nolangarryp tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT schurchchristianm tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy
AT rogallastephan tissueatlasofulcerativecolitisrevealingevidenceofsexdependentdifferencesindiseasedrivinginflammatorycelltypesandresistancetotnfinhibitortherapy